Studies using mouse xenograft models in addition to a RCC tissue microarray analysis of 40 paired patient samples indicated that UFL1 and UfBP1 can act as tumor inhibitors by regulating p53 stability [21]. This evidence concerns the gene UFL1 and renal cell carcinoma.